Dr. María Luisa Montes is a specialist in Internal Medicine and she works as clinician at the HIV Unit of La Paz University Hospital, Madrid, which provides care to over 4,000 individuals with HIV. Membership of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) and of the AIDS Study Group (GeSIDA) since 2001.
She has extensive experience in HIV and HIV-HCV co-infection, having participated in more than 80 clinical trials, including antiretroviral therapies, direct-acting antivirals for HCV, and innovative treatment strategies, both as a principal investigator and a collaborator. Her doctoral thesis focused on antiretroviral treatment and its complications.
Dr. Montes has been involved in numerous publicly funded research projects, addressing topics such as HCV treatment, cirrhosis in HIV patients, elastography in cirrhotic HIV patients, and antiretroviral therapy toxicity. Since 2016, following the near eradication of chronic HCV-related liver disease among HIV patients, Dr. Montes has established a new research and clinical focus on non-viral liver diseases. She led an FIS-funded project investigating non-viral liver diseases in HIV-infected individuals. She has formed a multidisciplinary team at La Paz Hospital, collaborating with specialists in hepatology, medical genetics, and translational research. Her recent publications have focused on research into hepatic steatosis, insulin resistance, and type 2 diabetes mellitus in people living with HIV.
